Landmark NHS England Report: Science Doesn’t Support Gender-Affirming Medicine

by Jane Coleman at

For years, critics have raised serious concerns over the shoddy evidence behind gender-affirming care, the aggressive, no-questions-asked model for treating gender dysphoria in young people.

Those critics now have a powerful ally in England, according to a landmark report commissioned by the National Health Service (NHS) and released last evening, April 9. The leader of the four-year study, Dr. Hilary Cass, just confirmed what they’ve been saying all along: gender medicine is “built on shaky foundations” and the evidence used to justify it is “remarkably weak.”

As we wrote here, the American Academy of Pediatrics recently doubled down on its commitment to gender-affirming care, tossing aside the traditional “watching and waiting” protocol. Under that approach, doctors proceeded with caution, allowing gender-dysphoric children to naturally progress through puberty while treating them with counseling and psychotherapy rather than sex-altering drugs.

But now, based on evidence that has been challenged as fraudulent and misleading, doctors readily “affirm” a child’s stated desire to change genders by prescribing puberty-blocking drugs, cross-sex hormones, and irreversible surgeries.

Meanwhile, the number of detransitioners who have come to regret these life-altering drugs and procedures is mounting, and so are the lawsuits, including ones we’ve covered here. They say they were used as guinea pigs to test out a reckless, unscientific treatment plan.

The new report from England agrees.